CRI Funded Scientists

Andreas Plueckthun, PhD, Technology Impact Award Recipient

University of Zurich

Area of Research: All Cancers

Projects and Grants

The SHREAD gene therapy platform for the safer delivery of Narrow Therapeutic Index (NTI) immunotherapeutics directly to the tumor microenvironment

University of Zurich | All Cancers | 2021

This website uses tracking technologies, such as cookies, to provide a better user experience. If you continue to use this site, then you acknowledge our use of tracking technologies. For additional information, review our Privacy Policy.